Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v1-EN
Language French English
Date Updated 2025-04-22 2024-12-10
Drug Identification Number 02279436 02279436
Brand name ONDANSETRON INJECTION USP -(WITH PRESERVATIVE) ONDANSETRON INJECTION USP -(WITH PRESERVATIVE)
Common or Proper name ONDANSETRON injection ONDANSETRON injection
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients ONDANSETRON ONDANSETRON
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 20ML 20ML
ATC code A04AA A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2024-12-09 2024-12-09
Estimated end date 2025-04-18 2025-02-07
Actual end date 2025-04-21
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments